Associations Between Functional TNFR2 196 M/R Polymorphisms and Susceptibility to Rheumatoid Arthritis: a Meta-analysis

Overview

Journal Rheumatol Int

Specialty Rheumatology

Date 2014 Apr 30

PMID 24777778

Citations 6

Authors

Gwan Gyu Song

Sang-Cheol Bae

Young Ho Lee

Affiliations

Soon will be listed here.

Abstract

Several studies have examined the effects of tumor necrosis factor receptor (TNFR) 1 +38 A/G and TNFR2 196 M/R polymorphisms on susceptibility to RA and have reported conflicting results. The purpose of this study was to examine whether the TNFR1 +38 A/G and TNFR2 196 M/R polymorphisms are associated with RA susceptibility. We performed a literature search using the Medical Literature Analysis and Retrieval System Online and Embase citation indices, and conducted a meta-analysis to examine the association between the TNFR1 +38 A/G and TNFR2 196 M/R polymorphisms and RA. Our meta-analysis included a total of 13 studies from 11 articles, consisting of 11 studies of the TNFR2 polymorphism (2,092 cases and 1,483 controls), and two studies of the TNFR1 polymorphism (672 cases and 288 controls). The meta-analysis revealed a significant association between the TNFR2 196 RR genotype and RA risk (OR 1.737, 95 % CI 1.275-2.367, P = 4.6 × 10(-5)). Stratification by ethnicity indicated an association between the TNFR2 196 RR genotype and RA in Europeans (OR 2.054, 95 % CI 1.305-3.232, P = 0.002), but not in East Asians (OR 1.596, 95 % CI 0.642-3.971, P = 0.314). Analysis using a homozygote contrast model showed the same pattern for the TNFR2 196 RR genotype in a European and East Asian population. However, no association was found between the TNFR1 +36 A/G polymorphism and RA in a European population. Our meta-analysis demonstrated that the functional TNFR2 196 M/R polymorphism is associated with susceptibility to RA in the European population.

Citing Articles

Gene Variants in Clinicopathological Aspects and Prognosis of Patients with Cutaneous Melanoma.

Carvalho B, Gomez G, Carron J, Macedo L, Goncalves G, de Lima Vazquez V Int J Mol Sci. 2024; 25(5).

PMID: 38474115 PMC: 10932403. DOI: 10.3390/ijms25052868.

The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response.

Moatti A, Cohen J Front Cell Dev Biol. 2021; 9:725473.

PMID: 34712661 PMC: 8546260. DOI: 10.3389/fcell.2021.725473.

Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response.

Mikhaylenko D, Nemtsova M, Bure I, Kuznetsova E, Alekseeva E, Tarasov V Int J Mol Sci. 2020; 21(14).

PMID: 32664585 PMC: 7402327. DOI: 10.3390/ijms21144911.

TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells.

Raphael I, Gomez-Rivera F, Raphael R, Robinson R, Nalawade S, Forsthuber T JCI Insight. 2019; 4(24).

PMID: 31852844 PMC: 6975265. DOI: 10.1172/jci.insight.132527.

A New Venue of TNF Targeting.

Steeland S, Libert C, Vandenbroucke R Int J Mol Sci. 2018; 19(5).

PMID: 29751683 PMC: 5983675. DOI: 10.3390/ijms19051442.

References

Yen J, Tsai W, Chen C, Ou T, Lin C, Hu C . Tumor necrosis factor receptor 2 microsatellite and exon 6 polymorphisms in rheumatoid arthritis in Taiwan. J Rheumatol. 2003; 30(3):438-42. View

Lee Y, Rho Y, Choi S, Ji J, Song G, Nath S . The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis. Rheumatology (Oxford). 2006; 46(1):49-56. DOI: 10.1093/rheumatology/kel170. View

Seitzer U, Swider C, Stuber F, Suchnicki K, Lange A, Richter E . Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine. 1997; 9(10):787-90. DOI: 10.1006/cyto.1997.0224. View

Choi S, Rho Y, Ji J, Song G, Lee Y . Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford). 2005; 45(2):166-70. DOI: 10.1093/rheumatology/kei128. View

Lee Y, Rho Y, Choi S, Ji J, Song G . Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int. 2006; 27(2):157-61. DOI: 10.1007/s00296-006-0175-7. View

Kim H, Heo Y, Jeong K, Kim Y, Jang H, Lee K . FGF-2 inhibits TNF-α mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cells. BMB Rep. 2012; 45(5):287-92. DOI: 10.5483/bmbrep.2012.45.5.287. View

Somoskovi A, Zissel G, Seitzer U, Gerdes J, Schlaak M . Polymorphisms at position -308 in the promoter region of the TNF-alpha and in the first intron of the TNF-beta genes and spontaneous and lipopolysaccharide-induced TNF-alpha release in sarcoidosis. Cytokine. 1999; 11(11):882-7. DOI: 10.1006/cyto.1999.0498. View

Fabris M, Tolusso B, Di Poi E, Assaloni R, Sinigaglia L, Ferraccioli G . Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis. J Rheumatol. 2002; 29(9):1847-50. View

Dieude P, Petit E, Cailleau-Moindrault S, Osorio J, Pierlot C, Martinez M . Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity. Arthritis Rheum. 2002; 46(8):2039-44. DOI: 10.1002/art.10101. View

10.

Glossop J, Dawes P, Mattey D . Antinuclear antibodies are associated with tumor necrosis factor receptor I gene polymorphism in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2011; 29(4):609-15. View

11.

Goeb V, Dieude P, Vittecoq O, Mejjad O, Menard J, Thomas M . Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis. Arthritis Res Ther. 2005; 7(5):R1056-62. PMC: 1257430. DOI: 10.1186/ar1777. View

12.

Yamaguchi E, Itoh A, Hizawa N, Kawakami Y . The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest. 2001; 119(3):753-61. DOI: 10.1378/chest.119.3.753. View

13.

Hussein Y, Mohamed R, Pasha H, El-Shahawy E, Alzahrani S . Association of tumor necrosis factor alpha and its receptor polymorphisms with rheumatoid arthritis in female patients. Cell Immunol. 2011; 271(1):192-6. DOI: 10.1016/j.cellimm.2011.06.023. View

14.

Pandey J, Frederick M . TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis. Hum Immunol. 2002; 63(6):485-91. DOI: 10.1016/s0198-8859(02)00399-3. View

15.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

16.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

17.

Heilig B, Mapara M, Brockhaus M, Krauth K, Dorken B . Two types of TNF receptors are expressed on human normal and malignant B lymphocytes. Clin Immunol Immunopathol. 1991; 61(2 Pt 1):260-7. DOI: 10.1016/s0090-1229(05)80029-7. View

18.

You C, Li X, Li Y, Wang L, Li F, Guo X . Association analysis of single nucleotide polymorphisms of proinflammatory cytokine and their receptors genes with rheumatoid arthritis in northwest Chinese Han population. Cytokine. 2012; 61(1):133-8. DOI: 10.1016/j.cyto.2012.09.007. View

19.

Lee Y, Rho Y, Choi S, Ji J, Song G . PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int. 2007; 27(9):827-33. DOI: 10.1007/s00296-007-0320-y. View

20.

Egger M, Smith G, Phillips A . Meta-analysis: principles and procedures. BMJ. 1998; 315(7121):1533-7. PMC: 2127925. DOI: 10.1136/bmj.315.7121.1533. View